Ticker brief
OABI
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
28
authors 14d
20
crowd 14d
+0.54
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-21 · now +0.45 (−1 bearish … +1 bullish)
Who spoke20
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @BAlmohsin1 | C | -0.91 | 3 | +0.37 |
| @Brad_E_Schulz | C | · | 3 | +0.00 |
| @wallstengine | B | -1.90 | 2 | +0.53 |
| @EmmanuelInvest | C | -1.11 | 2 | +0.62 |
| @Briefingcom | B | +0.50 | 2 | +0.45 |
| @OptionsFlowBoss | C | · | 2 | +0.35 |
| @MrGannabc | C | -0.45 | 1 | +0.50 |
| @DekmarTrades | C | -1.24 | 1 | +0.40 |
| @dmdt14 | C | -1.88 | 1 | +0.65 |
| @theflynews | C | · | 1 | +0.45 |
| @doublejtrading | C | -1.82 | 1 | +0.00 |
| @BankTheTrade | C | +1.63 | 1 | +0.65 |
| @OpenOutcrier | C | · | 1 | +0.60 |
| @optionscjp | C | -1.28 | 1 | +0.50 |
| @Volume_Stocks | C | -3.24 | 1 | +0.50 |
| @MartinShkreli | B | +1.42 | 1 | +0.80 |
| @AlertsAndNews | C | -1.90 | 1 | +0.50 |
| @AponiaAnalytics | B | +4.91 | 1 | +0.60 |
| @equitydd | C | -2.03 | 1 | +0.75 |
| @Optimalinvestme | C | +1.55 | 1 | +0.45 |
Recent signals28of 28 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-21 | @Optimalinvestme | +0.45 | Lists stocks bought and held before the close; output is capped at the first six tickers. | · | tweet ↗ |
| 2026-08-20 | @equitydd | +0.75 | Bullish OABI thesis cites partners, pipeline growth, royalties and raised 2026 guidance. | · | tweet ↗ |
| 2026-08-18 | @OptionsFlowBoss | +0.00 | Presents OABI open-interest changes without a stated direction. | · | tweet ↗ |
| 2026-08-18 | @BAlmohsin1 | +0.60 | The author recaps hypothetical gains from four completed educational setups during Monday's session. | · | tweet ↗ |
| 2026-08-17 | @Brad_E_Schulz | +0.00 | Lists stocks gaining at least 4% on elevated volume; capped at the first six names. | · | tweet ↗ |
| 2026-08-17 | @AponiaAnalytics | +0.60 | Argues Lilly's $370M collaboration validates a broader OABI discovery platform. | · | tweet ↗ |
| 2026-08-17 | @BAlmohsin1 | +0.50 | Arabic recap reports simulated gains across four completed educational trades. | · | tweet ↗ |
| 2026-08-17 | @OptionsFlowBoss | +0.70 | Quantifies unusual bullish options volume across several stocks. | · | tweet ↗ |
| 2026-08-17 | @Brad_E_Schulz | +0.00 | Reports intraday sector returns, breadth and leaders; capped at the first six directly quantified tickers. | · | tweet ↗ |
| 2026-08-17 | @Brad_E_Schulz | +0.00 | Lists stocks up at least 4% on elevated average volume; capped at the first six names. | · | tweet ↗ |
| 2026-08-17 | @AlertsAndNews | +0.50 | OmniAb announced a licensing collaboration with Eli Lilly worth up to $370M. | · | tweet ↗ |
| 2026-08-17 | @MartinShkreli | +0.80 | Bullish OABI thesis cites a newly announced Lilly deal and a $15 author target. | · | tweet ↗ |
| 2026-08-17 | @BAlmohsin1 | +0.00 | Premarket watchlist explicitly says inclusion does not mean entry. | · | tweet ↗ |
| 2026-08-17 | @Volume_Stocks | +0.50 | Premarket roundup reports distinct partnerships, insider buying, supply momentum and deployment milestones. | · | tweet ↗ |
| 2026-08-17 | @optionscjp | +0.50 | Premarket list reports direct catalysts including deals, buyback, earnings, initiation and a Phase 3 miss. | · | tweet ↗ |
| 2026-08-17 | @Briefingcom | +0.50 | OmniAb signed a Lilly collaboration and license deal and raised 2026 cash guidance. | · | tweet ↗ |
| 2026-08-17 | @OpenOutcrier | +0.60 | OmniAb announced a global collaboration and licensing agreement with Eli Lilly. | · | tweet ↗ |
| 2026-08-17 | @Briefingcom | +0.40 | Lists the largest premarket gaps, capped at the first six tickers by stated move magnitude. | · | tweet ↗ |
| 2026-08-17 | @BankTheTrade | +0.65 | Reports a global licensing collaboration under which OmniAb may receive up to $370M plus royalties from Lilly. | · | tweet ↗ |
| 2026-08-17 | @doublejtrading | +0.00 | Publishes a broad gapper list without individual directional interpretation. | · | tweet ↗ |
| 2026-08-17 | @theflynews | +0.45 | Reports OmniAb's collaboration and license agreement with Eli Lilly. | · | tweet ↗ |
| 2026-08-17 | @dmdt14 | +0.65 | Reports OABI broke 3.90, identifies 3.80 support, and watches 4.60 | · | tweet ↗ |
| 2026-08-17 | @EmmanuelInvest | +0.50 | OmniAb raises year-end cash guidance and announces a milestone-rich Lilly collaboration. | · | tweet ↗ |
| 2026-08-17 | @DekmarTrades | +0.40 | OmniAb announced a collaboration and licensing agreement with Eli Lilly. | · | tweet ↗ |
| 2026-08-17 | @EmmanuelInvest | +0.75 | OmniAb and Lilly announce a global licensing collaboration worth up to $370M plus royalties. | · | tweet ↗ |
| 2026-08-17 | @MrGannabc | +0.50 | Lists breakout, upside objectives and stop levels without explicit entry intent. | · | tweet ↗ |
| 2026-08-17 | @wallstengine | +0.50 | OmniAb raised its 2026 year-end cash guidance to $49M-$53M from $37M-$41M. | · | tweet ↗ |
| 2026-08-17 | @wallstengine | +0.55 | OmniAb signed a global drug-discovery collaboration with Lilly worth up to $370M plus royalties. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.